Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.

Deandreis D, Leboulleux S, Dromain C, Auperin A, Coulot J, Lumbroso J, Deschamps F, Rao P, Schlumberger M, de Baère T.

Radiology. 2011 Jan;258(1):270-6. doi: 10.1148/radiol.10092440. Epub 2010 Nov 2.

PMID:
21045185
2.

PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?

Sainani NI, Shyn PB, Tatli S, Morrison PR, Tuncali K, Silverman SG.

J Vasc Interv Radiol. 2011 Mar;22(3):354-60. doi: 10.1016/j.jvir.2010.11.027.

PMID:
21353987
3.

Dexamethasone Suppression FDG PET/CT for Differentiating between True- and False-Positive Pulmonary and Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer: A Pilot Study of FDG PET/CT after Oral Administration of Dexamethasone.

Nakajo M, Nakajo M, Nakayama H, Jinguji M, Nakabeppu Y, Higashi M, Nakamura Y, Sato M, Yoshiura T.

Radiology. 2016 Apr;279(1):246-53. doi: 10.1148/radiol.2015150883. Epub 2015 Nov 16.

PMID:
26579562
4.

18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.

Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H.

J Nucl Med. 2010 Dec;51(12):1833-40. doi: 10.2967/jnumed.110.076778. Epub 2010 Nov 15. Erratum in: J Nucl Med. 2011 Jan;52(1):106.

5.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
6.

Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.

Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Koyama K, Inoue K, Nakamura K, Inoue Y.

Ann Nucl Med. 2006 Feb;20(2):115-21.

PMID:
16615420
7.

Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.

Venkatesan AM, Kadoury S, Abi-Jaoudeh N, Levy EB, Maass-Moreno R, Krücker J, Dalal S, Xu S, Glossop N, Wood BJ.

Radiology. 2011 Sep;260(3):848-56. doi: 10.1148/radiol.11101985. Epub 2011 Jul 6.

8.

Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.

Radiology. 2005 Sep;236(3):1011-9. Epub 2005 Jul 12.

PMID:
16014441
9.

Impact of 18F-FDG-PET/CT on treatment strategy in colorectal cancer lung metastasis before lung radiofrequency ablation.

Kodama H, Yamakado K, Takaki H, Suzawa N, Yamada T, Takeda K.

Nucl Med Commun. 2013 Jul;34(7):689-93. doi: 10.1097/MNM.0b013e328361cd28.

PMID:
23636294
10.

Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?

Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.

Radiology. 2007 Jul;244(1):257-62.

PMID:
17581905
11.

Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.

Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D, Baron O, Despins P.

Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6. doi: 10.1016/j.ejcts.2009.05.044. Epub 2009 Jul 25.

PMID:
19632852
12.

Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.

Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, Shim YM, Kim J, Kim S.

Radiology. 2006 Nov;241(2):501-9. Epub 2006 Sep 11.

PMID:
16966480
13.

Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance.

Hess A, Palussière J, Goyers JF, Guth A, Aupérin A, de Baère T.

Radiology. 2011 Feb;258(2):635-42. doi: 10.1148/radiol.10100771.

PMID:
21273525
14.

Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.

Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y.

Acta Radiol. 2010 Mar;51(2):150-5. doi: 10.3109/02841850903485763.

PMID:
20092375
15.

Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.

Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ.

J Clin Oncol. 2002 Nov 15;20(22):4453-8.

PMID:
12431968
16.

Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.

Suzawa N, Yamakado K, Takao M, Taguchi O, Yamada T, Takeda K.

Clin Nucl Med. 2013 Apr;38(4):e166-70. doi: 10.1097/RLU.0b013e31828166f6.

PMID:
23429399
17.

Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.

Akeboshi M, Yamakado K, Nakatsuka A, Hataji O, Taguchi O, Takao M, Takeda K.

J Vasc Interv Radiol. 2004 May;15(5):463-70.

PMID:
15126656
18.

Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.

Ryan ER, Sofocleous CT, Schöder H, Carrasquillo JA, Nehmeh S, Larson SM, Thornton R, Siegelbaum RH, Erinjeri JP, Solomon SB.

Radiology. 2013 Jul;268(1):288-95. doi: 10.1148/radiol.13121462. Epub 2013 Apr 5.

19.

A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.

Higuchi M, Honjo H, Shigihara T, Shishido F, Suzuki H, Gotoh M.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1957-63. doi: 10.1007/s00432-014-1743-y. Epub 2014 Jun 21.

PMID:
24952227
20.

High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

Strobel K, Dummer R, Husarik DB, Pérez Lago M, Hany TF, Steinert HC.

Radiology. 2007 Aug;244(2):566-74.

PMID:
17641374

Supplemental Content

Support Center